Track the ACCURAY INCORPORATED share price and the full insider trade history of the company, a publicly traded company based in United States. Shares are quoted on the US market, under the supervision of SEC (Form 4). Market capitalisation: €32.7m. The latest transaction was disclosed on 12 June 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: LEONEL PERALTA. The full history is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
ACCURAY INCORPORATED 是一家专注于开发用于癌症治疗的放射治疗系统的公司。该公司在 XNAS 市场上市。